References used for this fact sheet
- Baade, P.D., Steginga, S.K., Pinnock, C.B. & Aitken, J.F., ‘Communicating prostate cancer risk: what should we be telling our patients?’ in Medical Journal of Australia, 2005, vol. 182. no. 9, pp. 472–5. More information here.
- Evidence-based recommendations for the management of localised prostate cancer, Australian Cancer Network. More information here.
- Satariano, W.A., Ragland, K.E. & Van Den Eeden, S.K., ‘Cause of death in men diagnosed with prostate carcinoma’, in Cancer, 1998, vol. 83, no. 6, pp. 1180–8. More information here.
- USANZ Prostate Cancer Testing Policy (2009), Urological Society of Australia and New Zealand. More information here.
- Schroder, F.H., Hugosson, J., Roobol, M.J., Tammela, T. L.J., Ciatto, S. Nelen, V., et al. (2009), ‘Screening and prostate-cancer mortality in a randomized European study’, in New England Journal of Medicine, vol. 360, no. 13, p. 18. More information here.
- Prostate cancer screening position statement [online], Cancer Council Victoria. More information here.
|
|
